The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus: a substrate for SSRIs therapeutic effects?
about
From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?Oxytocin and vasopressin: linking pituitary neuropeptides and their receptors to social neurocircuitsNovel oxytocin gene expression in the hindbrain is induced by alcohol exposure: transgenic zebrafish enable visualization of sensitive neuronsA Role for Oxytocin in the Etiology and Treatment of Schizophrenia.Oxytocin in schizophrenia: a review of evidence for its therapeutic effects.Oxytocin and Major Depressive Disorder: Experimental and Clinical Evidence for Links to Aetiology and Possible TreatmentPotential of Oxytocin in the Treatment of SchizophreniaSwitching brain serotonin with oxytocin.No association between oxytocin or prolactin gene variants and childhood-onset mood disorders.Oxytocin and postpartum depression: delivering on what's known and what's not.The utility of zebrafish to study the mechanisms by which ethanol affects social behavior and anxiety during early brain development.Oxytocin treatment in pediatric populationsEffects of selective serotonin reuptake inhibitor treatment on plasma oxytocin and cortisol in major depressive disorderPlasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study.Enhanced responsiveness to selective serotonin reuptake inhibitors during lactation.Differential serotonin transport is linked to the rh5-HTTLPR in peripheral blood cells.The effects of gestational stress and Selective Serotonin reuptake inhibitor antidepressant treatment on structural plasticity in the postpartum brain--A translational model for postpartum depressionImaging of serotonin transporters with [123I]FP-CIT SPECT in the human hypothalamus.Variants in Adjacent Oxytocin/Vasopressin Gene Region and Associations with ASD Diagnosis and Other Autism Related Endophenotypes.Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems.Oxytocin receptor (OXTR) and serotonin transporter (5-HTT) genes associated with observed parenting.Acute responsivity of the serotonergic system to S-citalopram and positive emotionality-the moderating role of the 5-HTTLPR.Orgasm, Serotonin Reuptake Inhibition, and Plasma Oxytocin in Obsessive-Compulsive Disorder. Gleaning From a Distant Randomized Clinical Trial.A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models.Decreased serotonin transporter immunoreactivity in the human hypothalamic infundibular nucleus of overweight subjects.The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish.A refined high carbohydrate diet is associated with changes in the serotonin pathway and visceral obesity.Fibroblast growth factor 2 alters the oxytocin receptor in a developmental model of anxiety-like behavior in male rat pups.A candidate circuit approach to investigating autism.Implicit association to infant faces: Genetics, early care experiences, and cultural factors influence caregiving propensities.A pilot study of serotonergic modulation after long-term administration of oxytocin in autism spectrum disorder.Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers.Plasma Oxytocin Level and Sexual Dysfunction in Depressed Women Treated by Either Fluoxetine or Citalopram: a Pilot Clinical Trial.
P2860
Q24648383-527A98F7-C582-44C5-A813-E7F660B7C010Q26781668-9499EE20-B032-42AC-A5BB-D5124133AB02Q28312143-95BDD719-623E-4E22-8833-1F126B7A83BCQ30408983-3F2F1C66-2F21-45C4-844E-CD72013C3EDDQ30453929-54AE6EAC-EFDD-451D-BFE5-6C6FE4305C4AQ33664227-E8B8DCC7-1B75-4ADE-9AED-A656AE1BC44DQ33761384-8830B54C-27D1-494E-B72D-09A0D57C6B57Q33767701-81C9A9A8-5FB8-4475-8BBE-173E02EC8AA5Q34137957-CAF482C8-9429-42BF-882A-53A1EDCD74DEQ34143400-CF588484-494F-445F-9039-108E344DDC9BQ34294142-E53FDA89-1EE9-44EC-9946-423D1F88E679Q34349468-AB68FFBA-9681-47A6-A7EB-BBEB7523E913Q34694131-C38203FE-6036-4C40-9B85-11DCB2425B11Q35073549-88A4F42F-B68E-4899-B1FC-97B99AFCB78FQ35092485-B539CE4E-6CA3-4319-9A58-FD53721E4347Q35844326-2F380157-7DCB-4A11-982F-8B72492DF932Q36296964-D92D9260-9437-452F-9789-FD920025F14FQ36827950-D525DE34-0759-4B51-93A1-2E54FC58F6CCQ36892246-F2D2CDDB-AD5A-4558-BB0E-4AA8CAEBCFBAQ36901254-30BDFED1-8C12-4BEC-9564-999F630B65FCQ36913209-DB31584A-0575-4425-9D2B-7B7C59A21C61Q37112840-DD7C16B6-62D6-43BF-8C53-69F2C76C1E6BQ37218091-EF5919A6-6252-47AC-B35A-BF3D320D0A98Q38630519-D2B36EAC-A58E-4E12-A40A-99A0B06DD925Q39852735-5C90A187-93BD-4A22-8F4F-55F2224334C5Q41417939-1FE921FB-11E1-4BF8-B295-D2110879A273Q42126695-EA01EB33-0B19-4F8A-A946-077C97F61BE5Q47381036-7285B30C-EC3E-4569-BDAC-452882749193Q47575039-A8EE20F1-0E6A-4403-A6B4-1BB945DE182AQ47656201-43C5A9B3-F452-462C-B7BC-94BAC1D702E5Q47783539-94D852D4-A434-4213-B189-E4D6628E5E97Q50776441-6DDCA02E-2DFC-4079-BB9F-3CCF6C0615AAQ55039715-BC88937F-0B67-4B00-8656-5CA62F49122D
P2860
The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus: a substrate for SSRIs therapeutic effects?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
The interface of oxytocin-labe ...... for SSRIs therapeutic effects?
@en
The interface of oxytocin-labe ...... for SSRIs therapeutic effects?
@nl
type
label
The interface of oxytocin-labe ...... for SSRIs therapeutic effects?
@en
The interface of oxytocin-labe ...... for SSRIs therapeutic effects?
@nl
prefLabel
The interface of oxytocin-labe ...... for SSRIs therapeutic effects?
@en
The interface of oxytocin-labe ...... for SSRIs therapeutic effects?
@nl
P2093
P2860
P356
P1476
The interface of oxytocin-labe ...... for SSRIs therapeutic effects?
@en
P2093
Ana B F Emiliano
Thomaz Cruz
Valerie Pannoni
P2860
P2888
P304
P356
10.1038/SJ.NPP.1301206
P407
P577
2006-10-11T00:00:00Z